According to this latest study, the 2021 growth of Coronary Intervention Drug Eluting Stent will have significant change from previous year. By the most conservative estimates of global Coronary Intervention Drug Eluting Stent market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Coronary Intervention Drug Eluting Stent market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Coronary Intervention Drug Eluting Stent market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Below 40 µm

40 µm- 65 µm

Above 65 µm

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Hospital

Clinic

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Synlas GmbH

YILSON

BrosMed Medical

SCITECH Medical

Wellinq

Degania Silicone

Alvimedica

Interventional Medical Device Solutions

Comed BV

iVascular

LEPU Medical

Eurocor Tech GmbH

OrbusNeich

Endocor GmbH

Meril Life Sciences

Acrostak

Boston Scientific Corporation

B. Braun

Biotronik

Abbott

MicroPort Medical Group

Philips

Terumo Corporation

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Coronary Intervention Drug Eluting Stent Consumption 2016-2026

2.1.2 Coronary Intervention Drug Eluting Stent Consumption CAGR by Region

2.2 Coronary Intervention Drug Eluting Stent Segment by Type

2.2.1 Below 40 µm

2.2.2 40 µm- 65 µm

2.2.3 Above 65 µm

2.3 Coronary Intervention Drug Eluting Stent Sales by Type

2.3.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)

2.3.2 Global Coronary Intervention Drug Eluting Stent Revenue and Market Share by Type (2016-2021)

2.3.3 Global Coronary Intervention Drug Eluting Stent Sale Price by Type (2016-2021)

2.4 Coronary Intervention Drug Eluting Stent Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Coronary Intervention Drug Eluting Stent Sales by Application

2.5.1 Global Coronary Intervention Drug Eluting Stent Sale Market Share by Application (2016-2021)

2.5.2 Global Coronary Intervention Drug Eluting Stent Revenue and Market Share by Application (2016-2021)

2.5.3 Global Coronary Intervention Drug Eluting Stent Sale Price by Application (2016-2021)

3 Global Coronary Intervention Drug Eluting Stent by Company

3.1 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Company

3.1.1 Global Coronary Intervention Drug Eluting Stent Sales by Company (2019-2021)

3.1.2 Global Coronary Intervention Drug Eluting Stent Sales Market Share by Company (2019-2021)

3.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Company

3.2.1 Global Coronary Intervention Drug Eluting Stent Revenue by Company (2019-2021)

3.2.2 Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Company (2019-2021)

3.3 Global Coronary Intervention Drug Eluting Stent Sale Price by Company

3.4 Global Manufacturers Coronary Intervention Drug Eluting Stent Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Coronary Intervention Drug Eluting Stent Product Location Distribution

3.4.2 Players Coronary Intervention Drug Eluting Stent Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Coronary Intervention Drug Eluting Stent by Region

4.1 Global Coronary Intervention Drug Eluting Stent by Region

4.1.1 Global Coronary Intervention Drug Eluting Stent Sales by Region

4.1.2 Global Coronary Intervention Drug Eluting Stent Revenue by Region

4.2 Americas Coronary Intervention Drug Eluting Stent Sales Growth

4.3 APAC Coronary Intervention Drug Eluting Stent Sales Growth

4.4 Europe Coronary Intervention Drug Eluting Stent Sales Growth

4.5 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Growth

5 Americas

5.1 Americas Coronary Intervention Drug Eluting Stent Sales by Country

5.1.1 Americas Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021)

5.1.2 Americas Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021)

5.2 Americas Coronary Intervention Drug Eluting Stent Sales by Type

5.3 Americas Coronary Intervention Drug Eluting Stent Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Coronary Intervention Drug Eluting Stent Sales by Region

6.1.1 APAC Coronary Intervention Drug Eluting Stent Sales by Region (2016-2021)

6.1.2 APAC Coronary Intervention Drug Eluting Stent Revenue by Region (2016-2021)

6.2 APAC Coronary Intervention Drug Eluting Stent Sales by Type

6.3 APAC Coronary Intervention Drug Eluting Stent Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Coronary Intervention Drug Eluting Stent by Country

7.1.1 Europe Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021)

7.1.2 Europe Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021)

7.2 Europe Coronary Intervention Drug Eluting Stent Sales by Type

7.3 Europe Coronary Intervention Drug Eluting Stent Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Coronary Intervention Drug Eluting Stent by Country

8.1.1 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021)

8.1.2 Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021)

8.2 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Type

8.3 Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Coronary Intervention Drug Eluting Stent Distributors

10.3 Coronary Intervention Drug Eluting Stent Customer

11 Global Coronary Intervention Drug Eluting Stent Market Forecast

11.1 Global Coronary Intervention Drug Eluting Stent Forecast by Region

11.1.1 Global Coronary Intervention Drug Eluting Stent Forecast by Regions (2021-2026)

11.2.2 Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Coronary Intervention Drug Eluting Stent Forecast by Type

11.7 Global Coronary Intervention Drug Eluting Stent Forecast by Application

12 Key Players Analysis

12.1 Synlas GmbH

12.1.1 Synlas GmbH Company Information

12.1.2 Synlas GmbH Coronary Intervention Drug Eluting Stent Product Offered

12.1.3 Synlas GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Synlas GmbH Main Business Overview

12.1.5 Synlas GmbH Latest Developments

12.2 YILSON

12.2.1 YILSON Company Information

12.2.2 YILSON Coronary Intervention Drug Eluting Stent Product Offered

12.2.3 YILSON Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 YILSON Main Business Overview

12.2.5 YILSON Latest Developments

12.3 BrosMed Medical

12.3.1 BrosMed Medical Company Information

12.3.2 BrosMed Medical Coronary Intervention Drug Eluting Stent Product Offered

12.3.3 BrosMed Medical Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 BrosMed Medical Main Business Overview

12.3.5 BrosMed Medical Latest Developments

12.4 SCITECH Medical

12.4.1 SCITECH Medical Company Information

12.4.2 SCITECH Medical Coronary Intervention Drug Eluting Stent Product Offered

12.4.3 SCITECH Medical Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 SCITECH Medical Main Business Overview

12.4.5 SCITECH Medical Latest Developments

12.5 Wellinq

12.5.1 Wellinq Company Information

12.5.2 Wellinq Coronary Intervention Drug Eluting Stent Product Offered

12.5.3 Wellinq Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Wellinq Main Business Overview

12.5.5 Wellinq Latest Developments

12.6 Degania Silicone

12.6.1 Degania Silicone Company Information

12.6.2 Degania Silicone Coronary Intervention Drug Eluting Stent Product Offered

12.6.3 Degania Silicone Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Degania Silicone Main Business Overview

12.6.5 Degania Silicone Latest Developments

12.7 Alvimedica

12.7.1 Alvimedica Company Information

12.7.2 Alvimedica Coronary Intervention Drug Eluting Stent Product Offered

12.7.3 Alvimedica Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Alvimedica Main Business Overview

12.7.5 Alvimedica Latest Developments

12.8 Interventional Medical Device Solutions

12.8.1 Interventional Medical Device Solutions Company Information

12.8.2 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Product Offered

12.8.3 Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Interventional Medical Device Solutions Main Business Overview

12.8.5 Interventional Medical Device Solutions Latest Developments

12.9 Comed BV

12.9.1 Comed BV Company Information

12.9.2 Comed BV Coronary Intervention Drug Eluting Stent Product Offered

12.9.3 Comed BV Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Comed BV Main Business Overview

12.9.5 Comed BV Latest Developments

12.10 iVascular

12.10.1 iVascular Company Information

12.10.2 iVascular Coronary Intervention Drug Eluting Stent Product Offered

12.10.3 iVascular Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 iVascular Main Business Overview

12.10.5 iVascular Latest Developments

12.11 LEPU Medical

12.11.1 LEPU Medical Company Information

12.11.2 LEPU Medical Coronary Intervention Drug Eluting Stent Product Offered

12.11.3 LEPU Medical Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 LEPU Medical Main Business Overview

12.11.5 LEPU Medical Latest Developments

12.12 Eurocor Tech GmbH

12.12.1 Eurocor Tech GmbH Company Information

12.12.2 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Product Offered

12.12.3 Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Eurocor Tech GmbH Main Business Overview

12.12.5 Eurocor Tech GmbH Latest Developments

12.13 OrbusNeich

12.13.1 OrbusNeich Company Information

12.13.2 OrbusNeich Coronary Intervention Drug Eluting Stent Product Offered

12.13.3 OrbusNeich Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 OrbusNeich Main Business Overview

12.13.5 OrbusNeich Latest Developments

12.14 Endocor GmbH

12.14.1 Endocor GmbH Company Information

12.14.2 Endocor GmbH Coronary Intervention Drug Eluting Stent Product Offered

12.14.3 Endocor GmbH Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Endocor GmbH Main Business Overview

12.14.5 Endocor GmbH Latest Developments

12.15 Meril Life Sciences

12.15.1 Meril Life Sciences Company Information

12.15.2 Meril Life Sciences Coronary Intervention Drug Eluting Stent Product Offered

12.15.3 Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Meril Life Sciences Main Business Overview

12.15.5 Meril Life Sciences Latest Developments

12.16 Acrostak

12.16.1 Acrostak Company Information

12.16.2 Acrostak Coronary Intervention Drug Eluting Stent Product Offered

12.16.3 Acrostak Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Acrostak Main Business Overview

12.16.5 Acrostak Latest Developments

12.17 Boston Scientific Corporation

12.17.1 Boston Scientific Corporation Company Information

12.17.2 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Product Offered

12.17.3 Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Boston Scientific Corporation Main Business Overview

12.17.5 Boston Scientific Corporation Latest Developments

12.18 B. Braun

12.18.1 B. Braun Company Information

12.18.2 B. Braun Coronary Intervention Drug Eluting Stent Product Offered

12.18.3 B. Braun Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.18.4 B. Braun Main Business Overview

12.18.5 B. Braun Latest Developments

12.19 Biotronik

12.19.1 Biotronik Company Information

12.19.2 Biotronik Coronary Intervention Drug Eluting Stent Product Offered

12.19.3 Biotronik Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.19.4 Biotronik Main Business Overview

12.19.5 Biotronik Latest Developments

12.20 Abbott

12.20.1 Abbott Company Information

12.20.2 Abbott Coronary Intervention Drug Eluting Stent Product Offered

12.20.3 Abbott Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.20.4 Abbott Main Business Overview

12.20.5 Abbott Latest Developments

12.21 MicroPort Medical Group

12.21.1 MicroPort Medical Group Company Information

12.21.2 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Product Offered

12.21.3 MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.21.4 MicroPort Medical Group Main Business Overview

12.21.5 MicroPort Medical Group Latest Developments

12.22 Philips

12.22.1 Philips Company Information

12.22.2 Philips Coronary Intervention Drug Eluting Stent Product Offered

12.22.3 Philips Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.22.4 Philips Main Business Overview

12.22.5 Philips Latest Developments

12.23 Terumo Corporation

12.23.1 Terumo Corporation Company Information

12.23.2 Terumo Corporation Coronary Intervention Drug Eluting Stent Product Offered

12.23.3 Terumo Corporation Coronary Intervention Drug Eluting Stent Sales, Revenue, Price and Gross Margin (2019-2021)

12.23.4 Terumo Corporation Main Business Overview

12.23.5 Terumo Corporation Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Coronary Intervention Drug Eluting Stent Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Below 40 µm

Table 3. Major Players of 40 µm- 65 µm

Table 4. Major Players of Above 65 µm

Table 5. Global Coronary Intervention Drug Eluting Stent Sales by Type (2016-2021) & (K Units)

Table 6. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)

Table 7. Global Coronary Intervention Drug Eluting Stent Revenue by Type (2016-2021) & ($ million)

Table 8. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Type (2016-2021)

Table 9. Global Coronary Intervention Drug Eluting Stent Sale Price by Type (2016-2021)

Table 10. Global Coronary Intervention Drug Eluting Stent Sales by Application (2016-2021) & (K Units)

Table 11. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)

Table 12. Global Coronary Intervention Drug Eluting Stent Value by Application (2016-2021)

Table 13. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Application (2016-2021)

Table 14. Global Coronary Intervention Drug Eluting Stent Sale Price by Application (2016-2021)

Table 15. Global Coronary Intervention Drug Eluting Stent Sales by Company (2019-2021) & (K Units)

Table 16. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Company (2019-2021)

Table 17. Global Coronary Intervention Drug Eluting Stent Revenue by Company (2019-2021) ($ Millions)

Table 18. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Company (2019-2021)

Table 19. Global Coronary Intervention Drug Eluting Stent Sale Price by Company (2019-2021)

Table 20. Key Manufacturers Coronary Intervention Drug Eluting Stent Producing Area Distribution and Sales Area

Table 21. Players Coronary Intervention Drug Eluting Stent Products Offered

Table 22. Coronary Intervention Drug Eluting Stent Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Coronary Intervention Drug Eluting Stent Sales by Region (2016-2021) (K Units)

Table 26. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Region (2016-2021)

Table 27. Global Coronary Intervention Drug Eluting Stent Revenue by Region (2016-2021) & ($ Millions)

Table 28. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Region (2016-2021)

Table 29. Americas Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021) & (K Units)

Table 30. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2016-2021)

Table 31. Americas Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021) & ($ Millions)

Table 32. Americas Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2016-2021)

Table 33. Americas Coronary Intervention Drug Eluting Stent Sales by Type (2016-2021) & (K Units)

Table 34. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)

Table 35. Americas Coronary Intervention Drug Eluting Stent Sales by Application (2016-2021) & (K Units)

Table 36. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)

Table 37. APAC Coronary Intervention Drug Eluting Stent Sales by Region (2016-2021) & (K Units)

Table 38. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Region (2016-2021)

Table 39. APAC Coronary Intervention Drug Eluting Stent Revenue by Region (2016-2021) & ($ Millions)

Table 40. APAC Coronary Intervention Drug Eluting Stent Revenue Market Share by Region (2016-2021)

Table 41. APAC Coronary Intervention Drug Eluting Stent Sales by Type (2016-2021) & (K Units)

Table 42. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)

Table 43. APAC Coronary Intervention Drug Eluting Stent Sales by Application (2016-2021) & (K Units)

Table 44. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)

Table 45. Europe Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021) & (K Units)

Table 46. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2016-2021)

Table 47. Europe Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021) & ($ Millions)

Table 48. Europe Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2016-2021)

Table 49. Europe Coronary Intervention Drug Eluting Stent Sales by Type (2016-2021) & (K Units)

Table 50. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)

Table 51. Europe Coronary Intervention Drug Eluting Stent Sales by Application (2016-2021) & (K Units)

Table 52. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)

Table 53. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Country (2016-2021) & (K Units)

Table 54. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Country (2016-2021)

Table 55. Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue by Country (2016-2021) & ($ Millions)

Table 56. Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue Market Share by Country (2016-2021)

Table 57. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Type (2016-2021) & (K Units)

Table 58. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Type (2016-2021)

Table 59. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales by Application (2016-2021) & (K Units)

Table 60. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)

Table 61. Key and Potential Regions of Coronary Intervention Drug Eluting Stent

Table 62. Key Application and Potential Industries of Coronary Intervention Drug Eluting Stent

Table 63. Key Challenges of Coronary Intervention Drug Eluting Stent

Table 64. Key Trends of Coronary Intervention Drug Eluting Stent

Table 65. Coronary Intervention Drug Eluting Stent Distributors List

Table 66. Coronary Intervention Drug Eluting Stent Customer List

Table 67. Global Coronary Intervention Drug Eluting Stent Sales Forecast by Region (2021-2026) & (K Units)

Table 68. Global Coronary Intervention Drug Eluting Stent Consumption Market Forecast by Region

Table 69. Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Region (2021-2026) & ($ millions)

Table 70. Global Coronary Intervention Drug Eluting Stent Revenue Market Share Forecast by Region (2021-2026)

Table 71. Americas Coronary Intervention Drug Eluting Stent Sales Forecast by Country (2021-2026) & (K Units)

Table 72. Americas Coronary Intervention Drug Eluting Stent Revenue Forecast by Country (2021-2026) & ($ millions)

Table 73. APAC Coronary Intervention Drug Eluting Stent Sales Forecast by Region (2021-2026) & (K Units)

Table 74. APAC Coronary Intervention Drug Eluting Stent Revenue Forecast by Region (2021-2026) & ($ millions)

Table 75. Europe Coronary Intervention Drug Eluting Stent Sales Forecast by Country (2021-2026) & (K Units)

Table 76. Europe Coronary Intervention Drug Eluting Stent Revenue Forecast by Country (2021-2026) & ($ millions)

Table 77. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Forecast by Country (2021-2026) & (K Units)

Table 78. Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Global Coronary Intervention Drug Eluting Stent Sales Forecast by Type (2021-2026) & (K Units)

Table 80. Global Coronary Intervention Drug Eluting Stent Sales Market Share Forecast by Type (2021-2026)

Table 81. Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 82. Global Coronary Intervention Drug Eluting Stent Revenue Market Share Forecast by Type (2021-2026)

Table 83. Global Coronary Intervention Drug Eluting Stent Sales Forecast by Application (2021-2026) & (K Units)

Table 84. Global Coronary Intervention Drug Eluting Stent Sales Market Share Forecast by Application (2021-2026)

Table 85. Global Coronary Intervention Drug Eluting Stent Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 86. Global Coronary Intervention Drug Eluting Stent Revenue Market Share Forecast by Application (2021-2026)

Table 87. Synlas GmbH Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 88. Synlas GmbH Coronary Intervention Drug Eluting Stent Product Offered

Table 89. Synlas GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 90. Synlas GmbH Main Business

Table 91. Synlas GmbH Latest Developments

Table 92. YILSON Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 93. YILSON Coronary Intervention Drug Eluting Stent Product Offered

Table 94. YILSON Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 95. YILSON Main Business

Table 96. YILSON Latest Developments

Table 97. BrosMed Medical Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 98. BrosMed Medical Coronary Intervention Drug Eluting Stent Product Offered

Table 99. BrosMed Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 100. BrosMed Medical Main Business

Table 101. BrosMed Medical Latest Developments

Table 102. SCITECH Medical Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 103. SCITECH Medical Coronary Intervention Drug Eluting Stent Product Offered

Table 104. SCITECH Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 105. SCITECH Medical Main Business

Table 106. SCITECH Medical Latest Developments

Table 107. Wellinq Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 108. Wellinq Coronary Intervention Drug Eluting Stent Product Offered

Table 109. Wellinq Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 110. Wellinq Main Business

Table 111. Wellinq Latest Developments

Table 112. Degania Silicone Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 113. Degania Silicone Coronary Intervention Drug Eluting Stent Product Offered

Table 114. Degania Silicone Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 115. Degania Silicone Main Business

Table 116. Degania Silicone Latest Developments

Table 117. Alvimedica Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 118. Alvimedica Coronary Intervention Drug Eluting Stent Product Offered

Table 119. Alvimedica Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 120. Alvimedica Main Business

Table 121. Alvimedica Latest Developments

Table 122. Interventional Medical Device Solutions Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 123. Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Product Offered

Table 124. Interventional Medical Device Solutions Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 125. Interventional Medical Device Solutions Main Business

Table 126. Interventional Medical Device Solutions Latest Developments

Table 127. Comed BV Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 128. Comed BV Coronary Intervention Drug Eluting Stent Product Offered

Table 129. Comed BV Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 130. Comed BV Main Business

Table 131. Comed BV Latest Developments

Table 132. iVascular Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 133. iVascular Coronary Intervention Drug Eluting Stent Product Offered

Table 134. iVascular Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 135. iVascular Main Business

Table 136. iVascular Latest Developments

Table 137. LEPU Medical Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 138. LEPU Medical Coronary Intervention Drug Eluting Stent Product Offered

Table 139. LEPU Medical Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 140. LEPU Medical Main Business

Table 141. LEPU Medical Latest Developments

Table 142. Eurocor Tech GmbH Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 143. Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Product Offered

Table 144. Eurocor Tech GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 145. Eurocor Tech GmbH Main Business

Table 146. Eurocor Tech GmbH Latest Developments

Table 147. OrbusNeich Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 148. OrbusNeich Coronary Intervention Drug Eluting Stent Product Offered

Table 149. OrbusNeich Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 150. OrbusNeich Main Business

Table 151. OrbusNeich Latest Developments

Table 152. Endocor GmbH Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 153. Endocor GmbH Coronary Intervention Drug Eluting Stent Product Offered

Table 154. Endocor GmbH Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 155. Endocor GmbH Main Business

Table 156. Endocor GmbH Latest Developments

Table 157. Meril Life Sciences Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 158. Meril Life Sciences Coronary Intervention Drug Eluting Stent Product Offered

Table 159. Meril Life Sciences Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 160. Meril Life Sciences Main Business

Table 161. Meril Life Sciences Latest Developments

Table 162. Acrostak Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 163. Acrostak Coronary Intervention Drug Eluting Stent Product Offered

Table 164. Acrostak Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 165. Acrostak Main Business

Table 166. Acrostak Latest Developments

Table 167. Boston Scientific Corporation Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 168. Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Product Offered

Table 169. Boston Scientific Corporation Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 170. Boston Scientific Corporation Main Business

Table 171. Boston Scientific Corporation Latest Developments

Table 172. B. Braun Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 173. B. Braun Coronary Intervention Drug Eluting Stent Product Offered

Table 174. B. Braun Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 175. B. Braun Main Business

Table 176. B. Braun Latest Developments

Table 177. Biotronik Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 178. Biotronik Coronary Intervention Drug Eluting Stent Product Offered

Table 179. Biotronik Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 180. Biotronik Main Business

Table 181. Biotronik Latest Developments

Table 182. Abbott Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 183. Abbott Coronary Intervention Drug Eluting Stent Product Offered

Table 184. Abbott Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 185. Abbott Main Business

Table 186. Abbott Latest Developments

Table 187. MicroPort Medical Group Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 188. MicroPort Medical Group Coronary Intervention Drug Eluting Stent Product Offered

Table 189. MicroPort Medical Group Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 190. MicroPort Medical Group Main Business

Table 191. MicroPort Medical Group Latest Developments

Table 192. Philips Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 193. Philips Coronary Intervention Drug Eluting Stent Product Offered

Table 194. Philips Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 195. Philips Main Business

Table 196. Philips Latest Developments

Table 197. Terumo Corporation Basic Information, Coronary Intervention Drug Eluting Stent Manufacturing Base, Sales Area and Its Competitors

Table 198. Terumo Corporation Coronary Intervention Drug Eluting Stent Product Offered

Table 199. Terumo Corporation Coronary Intervention Drug Eluting Stent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 200. Terumo Corporation Main Business

Table 201. Terumo Corporation Latest Developments

List of Figures

Figure 1. Picture of Coronary Intervention Drug Eluting Stent

Figure 2. Coronary Intervention Drug Eluting Stent Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Coronary Intervention Drug Eluting Stent Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Coronary Intervention Drug Eluting Stent Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Coronary Intervention Drug Eluting Stent Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Below 40 µm

Figure 10. Product Picture of 40 µm- 65 µm

Figure 11. Product Picture of Above 65 µm

Figure 12. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020

Figure 13. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Type (2016-2021)

Figure 14. Coronary Intervention Drug Eluting Stent Consumed in Hospital

Figure 15. Global Coronary Intervention Drug Eluting Stent Market: Hospital (2016-2021) & (K Units)

Figure 16. Coronary Intervention Drug Eluting Stent Consumed in Clinic

Figure 17. Global Coronary Intervention Drug Eluting Stent Market: Clinic (2016-2021) & (K Units)

Figure 18. Coronary Intervention Drug Eluting Stent Consumed in Others

Figure 19. Global Coronary Intervention Drug Eluting Stent Market: Others (2016-2021) & (K Units)

Figure 20. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Application (2016-2021)

Figure 21. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Application in 2020

Figure 22. Coronary Intervention Drug Eluting Stent Revenue Market by Company in 2020 ($ Million)

Figure 23. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Company in 2020

Figure 24. Global Coronary Intervention Drug Eluting Stent Sales Market Share by Regions (2016-2021)

Figure 25. Global Coronary Intervention Drug Eluting Stent Revenue Market Share by Region in 2020

Figure 26. Americas Coronary Intervention Drug Eluting Stent Sales 2016-2021 (K Units)

Figure 27. Americas Coronary Intervention Drug Eluting Stent Revenue 2016-2021 ($ Millions)

Figure 28. APAC Coronary Intervention Drug Eluting Stent Sales 2016-2021 (K Units)

Figure 29. APAC Coronary Intervention Drug Eluting Stent Revenue 2016-2021 ($ Millions)

Figure 30. Europe Coronary Intervention Drug Eluting Stent Sales 2016-2021 (K Units)

Figure 31. Europe Coronary Intervention Drug Eluting Stent Revenue 2016-2021 ($ Millions)

Figure 32. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales 2016-2021 (K Units)

Figure 33. Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue 2016-2021 ($ Millions)

Figure 34. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Country in 2020

Figure 35. Americas Coronary Intervention Drug Eluting Stent Revenue Market Share by Country in 2020

Figure 36. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020

Figure 37. Americas Coronary Intervention Drug Eluting Stent Sales Market Share by Application in 2020

Figure 38. United States Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 39. Canada Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 40. Mexico Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 41. Brazil Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 42. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Region in 2020

Figure 43. APAC Coronary Intervention Drug Eluting Stent Revenue Market Share by Regions in 2020

Figure 44. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020

Figure 45. APAC Coronary Intervention Drug Eluting Stent Sales Market Share by Application in 2020

Figure 46. China Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 47. Japan Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 48. Korea Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 49. Southeast Asia Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 50. India Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 51. Australia Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 52. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Country in 2020

Figure 53. Europe Coronary Intervention Drug Eluting Stent Revenue Market Share by Country in 2020

Figure 54. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020

Figure 55. Europe Coronary Intervention Drug Eluting Stent Sales Market Share by Application in 2020

Figure 56. Germany Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 57. France Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 58. UK Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 59. Italy Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 60. Russia Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 61. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Country in 2020

Figure 62. Middle East & Africa Coronary Intervention Drug Eluting Stent Revenue Market Share by Country in 2020

Figure 63. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Type in 2020

Figure 64. Middle East & Africa Coronary Intervention Drug Eluting Stent Sales Market Share by Application in 2020

Figure 65. Egypt Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 66. South Africa Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 67. Israel Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 68. Turkey Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 69. GCC Country Coronary Intervention Drug Eluting Stent Revenue Growth 2016-2021 ($ Millions)

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles